Irvine, CA, United States of America

Antonio Romero

This inventor holds 1 USPTO granted patent. Top assignee: Pharmachem Technologies Limited. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Romero. Retrieved from https://idiyas.com/inventor/antonio-romero-mw04rn2b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Romero: Innovator in Pharmaceutical Processes

Introduction

Antonio Romero is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for antidepressant medications. His work is characterized by a commitment to innovation and improvement in drug preparation methods.

Latest Patents

Antonio holds a patent for a process related to the preparation of Citalopram intermediate. This invention provides a novel approach to the synthesis of Citalopram, a well-known antidepressant. His patent is a testament to his expertise and dedication to enhancing pharmaceutical processes. He has 1 patent to his name.

Career Highlights

Antonio is currently employed at Pharmachem Technologies Limited, where he applies his knowledge and skills to advance pharmaceutical technologies. His role at the company allows him to work on innovative projects that aim to improve drug efficacy and safety.

Collaborations

Antonio collaborates with talented professionals in his field, including Aslam A Malik and Hasan Palandoken. These partnerships enhance the quality of research and development efforts within the company.

Conclusion

Antonio Romero is a distinguished inventor whose work in pharmaceutical processes has made a significant impact on the industry. His dedication to innovation and collaboration continues to drive advancements in the preparation of essential medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…